Parkinson's Action Network interviews Dr. Ashley Harms
- Created on June 21, 2013
Parkinson's Action Network recently interviewed Dr. Ashley Harms, one of PAN's Alabama Assistant State Directors. Dr. Harms discusses her involvement with PAN, her Parkinson's research, and her views on the scientific community's role in advocacy.
Dr. Harms currently serves as a Post-Doctoral Trainee in the Department of Neurology, Center for Neurodegenerative and Experimental Therapeutics under the mentorship of Dr. David Standaert. To read the full interview click below:
Genetic Marker Enables Better Prediction of Warfarin Dose in Patients of African Ancestry
- Created on June 04, 2013
A new-found genetic marker promises to better predict warfarin dose in African Americans, according to a study published online in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patients's starting dose misses the drug's narrow safety window. To read the full story click below:
Study Finds Proof that Immune Defenses Amplify Parkinson's Disease Damage
- Created on June 04, 2013
The same mechanism that lets the immune system mount a massive attack against invading bacteria contributes to the destruction of brain cells as part of Parkinson’s disease, according to a study published online today in the Journal of Neuroscience.
Researchers from the University of Alabama at Birmingham (UAB) found that shutting down production of a key group of immune proteins, major histocompatibility complex II (MHCII), completely protected mice that displayed a “human version” of the disease from related nerve cell death.
The MHCII protein complex enables cells that first respond to infections to display pieces of bacteria or viruses on their surfaces for notice by a second part of the immune system. These displayed pieces of invaders trigger a massive, second wave of immune reactions led by T cells and B cells. While vital to body’s ability to combat infectious disease, full-scale immune responses cause disease-related inflammation and cell death when unleashed in the wrong place. To see the full story click below:
Gift will fund dystonia research at UAB
- Created on May 22, 2013
The University of Alabama at Birmingham has received a $1 million dollar gift from the family of Mrs. Joel E. Johnson, Jr., daughter-in-law of the late Joel E. Johnson, Sr., to enhance and strengthen the dystonia research program at UAB. Dystonia is a neurological movement disorder in which sustained muscle contractions cause twisting and repetitive movements or abnormal postures.
The Joel E. Johnson, Sr., Research Acceleration Fund in Dystonia will support ongoing dystonia research in the Division of Movement Disorders, part of the Department of Neurology.
This gift will help UAB create a world-class research program in dystonia.
- Dr. Anne Alexandrov receives top award from AACN
- Dr. Erik Roberson and Dr. Andy West appointed as Associate Directors of CNET - Center for Neurodegeneration and Experimental Therapeutics
- Dr. William Meador awarded training fellowship from The National MS Society
- Dr. Paula Province will be presenting Neurology Grand Rounds - "Eponymous Neurology: History, Mystery, Mythology"